Evaluation of the Safety and Efficacy of Using Insulin-like Growth Factor-1 in Patients With a Heart Attack

NCT01438086 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure
Myocardial Infarction

Interventions

DRUG: mecasermin
DRUG: mecasermin
DRUG: 0.9% sodium chloride injection

Sponsor

University College Cork